Botanix Pharmaceuticals
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - Industrial WABotanix is a medical dermatology company developing new prescription medicines to treat serious skin diseases, including acne, psoriasis and atopic dermatitis.
Botanix Pharmaceuticals Limited listed on the ASX in July 2016 through a reverse takover of Bone Medical.
Contact Details
Ground Floor, 16 Ord Street, WEST PERTH WA 6005
08 9482 0580
Lists and Charts
Public Companies - Industrial WA list sponsored by
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Botanix Pharmaceuticals | $6.9m |
209 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 30/09/21
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1189th | Botanix Pharmaceuticals | 0% |
1750 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Article Timeline
Company Activity
| NEWS: Tagged in Board Moves March 1, 2021 | 01 Mar 2021 |
| NEWS: Tagged in Research a driver for cannabis | 11 Dec 2020 |
| NEW ROLE: S Levy, Chief Medical Officer | 24 Nov 2020 |
| REMUNERATION UPDATE: William Bosch, Executive Director, Chief Scientific Advisor | 02 Nov 2020 |
| REMUNERATION UPDATE: Michael Thurn, Chief Operating Officer, Head of Australian Operations, Executive Director since 2019 | 02 Nov 2020 |
| REMUNERATION UPDATE: Vince Ippolito, Executive Chair, President | 02 Nov 2020 |
| REMUNERATION UPDATE: Robert Towner, Non-Executive Director | 02 Nov 2020 |
| REMUNERATION UPDATE: Stewart Washer, Non-Executive Director | 02 Nov 2020 |
| NEWS: Tagged in More than Linear growth for drug trials in COVID-free WA | 11 Sep 2020 |
| REMUNERATION UPDATE: William Bosch, Executive Director, Chief Scientific Advisor | 24 Aug 2020 |
